Travere Therapeutics, Inc. - Common Stock (TVTX)
CUSIP: 89422G107
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 89,403,587
- Total 13F shares
- 60,583,594
- Share change
- -1,176,556
- Total reported value
- $883,983,031
- Put/Call ratio
- 61%
- Price per share
- $14.59
- Number of holders
- 131
- Value change
- -$73,514,650
- Number of buys
- 68
- Number of sells
- 77
Quarterly Holders Quick Answers
What is CUSIP 89422G107?
CUSIP 89422G107 identifies TVTX - Travere Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89422G107:
Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.3%
|
5,614,428
|
$140,192,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
4,831,555
|
$120,645,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.1%
|
4,550,000
|
$113,614,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.6%
|
4,150,556
|
$103,639,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
4,001,588
|
$99,920,000 | — | 31 Mar 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.7%
|
3,298,419
|
$82,362,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.1%
|
2,737,553
|
$68,357,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
2,439,527
|
$60,915,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.7%
|
2,436,071
|
$60,828,000 | — | 31 Mar 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.6%
|
2,356,000
|
$58,829,000 | — | 31 Mar 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
2.6%
|
2,309,887
|
$57,678,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
1,608,126
|
$40,155,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.8%
|
1,588,722
|
$39,670,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.7%
|
1,476,479
|
$36,868,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.7%
|
1,475,564
|
$36,845,000 | — | 31 Mar 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.4%
|
1,249,000
|
$31,188,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
1,231,510
|
$30,749,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
957,246
|
$23,902,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.97%
|
867,226
|
$21,386,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.93%
|
827,434
|
$20,661,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
675,650
|
$16,871,000 | — | 31 Mar 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.72%
|
641,172
|
$16,010,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
640,921
|
$16,004,000 | — | 31 Mar 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.69%
|
618,520
|
$15,444,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
0.67%
|
599,599
|
$14,972,000 | — | 31 Mar 2021 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.66%
|
593,712
|
$14,825,000 | — | 31 Mar 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.59%
|
528,100
|
$13,187,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.5%
|
446,569
|
$11,151,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
435,682
|
$10,879,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.44%
|
391,091
|
$9,765,000 | — | 31 Mar 2021 | |
| AXA S.A. |
13F
|
Company |
0.36%
|
323,718
|
$8,083,000 | — | 31 Mar 2021 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.36%
|
321,234
|
$8,021,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.35%
|
314,817
|
$7,861,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.29%
|
263,013
|
$6,568,000 | — | 31 Mar 2021 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.28%
|
247,011
|
$6,167,000 | — | 31 Mar 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.25%
|
220,000
|
$5,493,000 | — | 31 Mar 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.24%
|
212,869
|
$5,315,000 | — | 31 Mar 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.24%
|
210,484
|
$5,256,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
206,412
|
$5,154,000 | — | 31 Mar 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.21%
|
186,915
|
$4,667,000 | — | 31 Mar 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.21%
|
185,395
|
$4,629,000 | — | 31 Mar 2021 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.2%
|
179,102
|
$4,473,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.19%
|
174,193
|
$4,349,000 | — | 31 Mar 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
0.19%
|
166,069
|
$4,147,000 | — | 31 Mar 2021 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.18%
|
163,371
|
$4,079,000 | — | 31 Mar 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.18%
|
158,475
|
$3,956,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.17%
|
151,108
|
$3,774,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.16%
|
140,680
|
$3,513,000 | — | 31 Mar 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.15%
|
130,161
|
$3,250,000 | — | 31 Mar 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.14%
|
126,533
|
$3,160,000 | — | 31 Mar 2021 |
Institutional Holders of Travere Therapeutics, Inc. - Common Stock (TVTX) as of Q2 2021
As of 30 Jun 2021,
Travere Therapeutics, Inc. - Common Stock (TVTX) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,583,594 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., MACQUARIE GROUP LTD, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, GOLDMAN SACHS GROUP INC, and PERCEPTIVE ADVISORS LLC.
This page lists
131
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
147
Q2 2021 holders
131
Holder diff
-16
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.